Captor Therapeutics ® Investor Relations

      Investor Relations

      Announcement of a break in the Ordinary General Meeting of Captor Therapeutics S.A. on 30 June 2022 and the content of the resolutions adopted until the break

      Publication date: 2022-06-30
      Number: RB ESPI 25/2022

      Current Report No. 25/2022

      Date of preparation: 30 June 2022

      Subject: Announcement of a break in the Ordinary General Meeting of Captor Therapeutics S.A. on 30 June 2022 and the content of the resolutions adopted until the break

      Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

      The Management Board of Captor Therapeutics S.A. (the "Company"), announces that on 30 June 2022 that the Ordinary General Meeting of the Company (the "OGM"), by Resolution No. 17 declared an adjournment of the meeting until 14 July 2022 at 14.00. After the break the session will be continued in Wrocław, 9 Duńska Street (54-427 Wrocław), in the DELTA building.

      The text of the resolutions adopted by the AGM on 30 June 2022 until the time of the adjournment is attached hereto.

      At the same time the Company informs that up to the moment of announcing a break in the session, the AGM did not withdraw from consideration of any of the items of the planned agenda. There were no objections to the adopted resolutions in the minutes.

       

      Detailed legal basis:

      §19 (1) items. 5-7 and 9 of the RMF on current and periodic information provided by issuers of securities and conditions for recognizing as equivalent information required by the laws of a non-member state


      Attachments: